Trinity Biotech
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $14,248 | $7,575 | $15,857 | $15,152 |
Gross Profit | 6,086 | 1,566 | 4,877 | 5,308 |
EBITDA | -115 | -5,848 | -9,598 | -1,112 |
EBIT | -772 | -6,486 | -10,022 | -1,710 |
Net Income | -5,112 | -8,803 | -16,956 | -4,759 |
Net Change In Cash | 14,248 | 7,575 | 15,857 | 15,152 |
Free Cash Flow | -77 | -3,018 | 615 | -6,323 |
Cash | 1,341 | 4,066 | 5,167 | 2,840 |
Basic Shares | 18,655 | 18,299 | 14,173 | 10,387 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $61,555 | $56,832 | $62,521 | $81,149 |
Gross Profit | 21,441 | 19,450 | 22,048 | 33,454 |
EBITDA | -16,905 | -24,098 | -16,713 | 10,592 |
EBIT | -18,770 | -25,874 | -19,046 | 7,848 |
Net Income | -31,789 | -24,018 | -41,002 | 875 |
Net Change In Cash | 61,555 | 56,832 | 62,521 | 81,149 |
Free Cash Flow | -14,255 | -12,360 | -6,898 | 4,547 |
Cash | 5,167 | 3,691 | 6,578 | 25,910 |
Basic Shares | 17,959 | 7,654 | 7,774 | 5,325 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.40 |
2025-03-31 | -$1.24 |
2024-12-31 | -$0.87 |
2024-09-30 | -$1.10 |
